®Biological Assurance Through Autologous Blood Banking.
Headquartered in Hong Kong, MiCells® is developing infrastructure for long-term personal blood banking, enabling individuals to preserve, monitor and maintain access to their own blood for future medical use.
Four principles behind long-term personal blood banking.
Medical Autonomy
Your blood. Your biology. Preserved under autologous protocols.
Clinical Integrity
Developed alongside senior medical professionals and governed by rigorous, independently reviewed standards.
Security & Traceability
Comprehensive chain-of-custody and asset verification throughout the entire preservation lifecycle.
Global Readiness
Designed to support international mobility and emergency responsiveness across jurisdictions.
Designed for individuals planning beyond conventional healthcare.
MiCells® supports individuals and families seeking long-term biological preparedness through clinically governed personal blood banking.
Five stages of custody.
- 01
Medical Consultation
Initial clinical assessment to determine suitability, individual considerations and a tailored preservation plan.
- 02
Collection & Verification
Controlled biological collection by accredited clinical partners, followed by identity, integrity and provenance verification.
- 03
Secure Preservation
Transfer into institutional preservation infrastructure under advanced cryogenic protocols and continuous monitoring.
- 04
Ongoing Stewardship
Lifecycle integrity management, periodic review, redundant storage architecture and confidential client reporting.
- 05
Mobilisation Upon Need
Coordinated release to the treating clinical institution with complete documented chain-of-custody.
Built upon clinical oversight.
The MiCells® framework is designed to be defensible to clinicians, auditors and regulators alike.
Medical Advisory Board
Senior medical professionals advising on clinical safety, suitability protocols and the evolving science of preservation.
Compliance Philosophy
A pro-active regulatory posture that anticipates institutional, cross-border and emerging compliance frameworks.
Clinical Governance
Independent governance over decisions impacting biological integrity, client safety and chain-of-custody.
Quality Assurance
Documented quality protocols across collection, transport, storage and mobilisation. Auditable end to end.
Advisory Board.
We welcome confidential advisory discussions.
Research & perspectives.
Register your expression of interest.
A confidential, non-binding channel for prospective clients of the MiCells® autologous blood banking programme. Your submission helps us plan capacity, refine our service design and prioritise engagement across Hong Kong and international markets.
Non-binding
No contract is created and no obligation arises on either side.
Held in confidence
Never sold, never shared with third parties. Withdrawable on request.
Forecasting purpose
Used only to model prospective client numbers and refine the offering.
Partners & Investors.
MiCells® is a Hong Kong-based healthcare infrastructure company operating at the intersection of preservation and long-term medical continuity. Engagement is by introduction and qualified enquiry.
Strategic Partnerships
Clinical, preservation, logistics and healthcare partners supporting the build-out of long-term personal blood banking infrastructure.
Medical & Strategic Advisory
Supporting clinical governance, regulatory development and long-term healthcare deployment.
Investor Enquiries
Qualified investor enquiries from family offices, institutional funds and aligned long-horizon capital.
Investor information is available on request to qualified parties.
Speak with MiCells®.
Enquiries are handled in confidence. A member of the MiCells® team will respond from info@micells.io.
Hong Kong SAR